Ambrosia artemisiifolia pollen

Overview

Ambrosia artemisiifolia pollen is the pollen of the Ambrosia artemisiifolia plant. Ambrosia artemisiifolia pollen is mainly used in allergenic testing.

Indication

Ambrosia artemisiifolia pollen is an allergen extract indicated as immunotherapy for the treatment of short ragweed pollen-induced allergic rhinitis, with or without conjunctivitis, confirmed by positive skin test or in vitro testing for pollen-specific IgE antibodies for short ragweed pollen. It is approved for use in persons five through 65 years of age. This allergen extract is not indicated for the immediate relief of allergic symptoms.

Associated Conditions

Allergic Rhinitis (AR)
Allergy to Tree Pollen
Asthma

Clinical Trials

Title	Posted	Study ID	Phase	Status	Sponsor

No clinical trials found

No clinical trials found for this drug

FDA Drug Approvals

Approved Product	Manufacturer	NDC Code	Route	Strength	Effective Date
Treatment Set TS346157	Antigen Laboratories, Inc.	49288-0854	SUBCUTANEOUS, INTRADERMAL	4000 [AU] in 1 mL	5/11/2012
Treatment Set TS334128	Antigen Laboratories, Inc.	49288-0772	SUBCUTANEOUS, INTRADERMAL	0.000027 g in 1 mL	12/2/2009
Treatment Set TS339185	Antigen Laboratories, Inc.	49288-0801	SUBCUTANEOUS, INTRADERMAL	0.00067 g in 1 mL	1/13/2011
Treatment Set TS345380	Antigen Laboratories, Inc.	49288-0846	SUBCUTANEOUS, INTRADERMAL	160 [AU] in 1 mL	3/23/2012
Treatment Set TS340826	Antigen Laboratories, Inc.	49288-0812	INTRADERMAL, SUBCUTANEOUS	0.0012 g in 1 mL	3/30/2011
Treatment Set TS345476	Antigen Laboratories, Inc.	49288-0849	SUBCUTANEOUS, INTRADERMAL	4000 g in 1 mL	5/11/2012
Treatment Set TS344059	Antigen Laboratories, Inc.	49288-0831	SUBCUTANEOUS, INTRADERMAL	20000 [AU] in 1 mL	12/29/2011
Treatment Set TS332147	Antigen Laboratories, Inc.	49288-0718	SUBCUTANEOUS, INTRADERMAL	0.0000267 g in 1 mL	12/2/2009
Treatment Set TS336437	Antigen Laboratories, Inc.	49288-0786	SUBCUTANEOUS, INTRADERMAL	0.0000266 g in 1 mL	6/17/2010
Treatment Set TS331975	Antigen Laboratories, Inc.	49288-0736	SUBCUTANEOUS, INTRADERMAL	0.0000267 g in 1 mL	12/2/2009

EMA Drug Approvals

Approved Product	Authorization Holder	Status	Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product	Manufacturer	Approval Number	Dosage Form	Strength	Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product	Company	Approval Number	Drug Type	Dosage Form	Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product	Registration No.	Company	Licence No.	Strength	Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product	ARTG ID	Sponsor	Registration Type	Status	Registration Date
RAGWEED MIX (FGSW) (1:20) Scratch test & treatment	32977	Stallergenes Australia Pty Ltd	Medicine	A	11/1/1991
Hayfever Oral Spray	351128	Brauer Natural Medicine Pty Ltd	Medicine	A	12/8/2020

Health Canada Drug Approvals

Approved Product	Company	DIN	Dosage Form	Strength	Market Date
RAGWITEK	ALK-ABELLO A/S	02423723	Tablet (Orally Disintegrating) - Sublingual	12 UNIT	4/29/2014

CIMA AEMPS Drug Approvals

Approved Product	Company	Registration Number	Pharmaceutical Form	Prescription Type	Status
No CIMA AEMPS (Spain) approvals found for this drug.

Philippines FDA Drug Approvals

Approved Product	Company	License Number	Dosage Form	Strength	Approval Date
No Philippines FDA approvals found for this drug.

Saudi SFDA Drug Approvals

Approved Product	Company	License Number	Dosage Form	Strength	Approval Date
No Saudi SFDA approvals found for this drug.

Malaysia NPRA Drug Approvals

Approved Product	Company	Registration Number	Dosage Form	Strength	Approval Date
No Malaysia NPRA approvals found for this drug.

UK EMC Drug Information

Medicine Name	MA Holder	MA Number	Pharmaceutical Form	Active Ingredient	Authorization Date
No UK EMC drug information found for this drug.

AI-Powered Research

Premium Access